| abstract |
The invention relates to compounds of formula: n n n and their solvates and/or hydrates exhibiting affinity for the arginine-vasopressin V 1b receptors or for both V 1b and V 1a receptors. n The invention also relates to their process of preparation, to the intermediate compounds of formula (II) of use for their preparation, to the pharmaceutical compositions comprising them and to their use for the preparation of medicaments. |